Rizatriptan-Mepha oro 5 mg, Schmelztabletten - 6 Tablette(n) Swissmedic Key 65799001 CM Registration Holder Mepha Pharma AG Name Rizatriptan-Mepha oro 5 mg, Schmelztabletten Date of registration 22.05.2015 Original/Generic Generic Introduction of Sequence 22.05.2015 ATC-Classification Rizatriptan (N02CC04) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.05.10. Show package size 6 Tablette(n) Index Therapeuticus (Swissmedic) 02.05.10. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 20.84 Limitation No Deductible 10 % Consumer price 39.10 Feedback FB Daily cost GTIN 7680657990010 Medication Code Synthetika Pharmacode 6146503 Disponibility
Composition rizatriptanum 5 mg ut rizatriptani benzoas, mannitolum, cellulosum microcristallinum, maltodextrinum, silica colloidalis anhydrica, crospovidonum, saccharinum natricum corresp. natrium 0.03 mg, aromatica (Menthol), amylum modificatum, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Melting tablets Active Agent Dose Rizatriptan 5 mg
BAG: Active Agent Dose Rizatriptan 5 mg
Inactive agents Amylum Modificatum Aromatica (Menthol) Cellulosum Microcristallinum Crospovidonum Magnesii Stearas Maltodextrine Mannitol Pro Compresso Saccharinum Natricum Silica Colloidalis Anhydrica
Source Data was imported : 04.02.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
